Canakinumab

Canakinumab is a human monoclonal antibody directed against interleukin 1 beta (IL1B). Canakinumab is being used in the treatment of of cryopyrin-associated periodic syndromes (CAPS).

What can Sanquin do for you?

Measure drug levels of free drug in the serum using an validated ELISA.
Measure the immunogenicity of canakinumab.
Provide assay reagents or co-develop novel testing strategies.
Folllowing ISO, FDA/EMA, RUO guidelines.

Enquire about our drug level and ADA assays by emailing us at [email protected].

Last edited on: 23 November 2022